Paper39720899
Relation of 91 Circulating Inflammatory Proteins to Nonalcoholic Fatty Liver Disease: A Two-Sample Mendelian Randomisation Study.
Wu X and 2 others. J Cell Mol Med, 2024. Cited by 4 papers, by iCite.
Cite this record
ConductScience Library. Relation of 91 Circulating Inflammatory Proteins to Nonalcoholic Fatty Liver Disease: A Two-Sample Mendelian Randomisation Study. Papers, record 39720899. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39720899
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Relation of 91 Circulating Inflammatory Proteins to Nonalcoholic Fatty Liver Disease: A Two-Sample Mendelian Randomisation Study.
- PubMed
Topics7
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Non-alcoholic Fatty Liver Disease | Major topic |
| Mendelian Randomization Analysis | Major topic |
| Inflammation | Major topic |
| Humans | |
| Polymorphism, Single Nucleotide | |
| Genetic Predisposition to Disease | |
| Biomarkers |
Source PubMed
References28
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 37563310 | Genetics of circulating inflammatory proteins identifies drivers of immune-mediated disease risk and therapeutic targets. | Nat Immunol | 2023 | https://conductscience.org/library/papers/37563310 | PubMed |
| 2 | 34275345 | Orally administered anti-eotaxin-1 monoclonal antibody is biologically active in the gut and alleviates immune-mediated hepatitis: A novel anti-inflammatory personalized therapeutic approach. | Int J Immunopathol Pharmacol | 2021 | https://conductscience.org/library/papers/34275345 | PubMed |
| 3 | 20454933 | Pro- and anti-inflammatory cytokines in steatosis and steatohepatitis. | Obes Surg | 2010 | https://conductscience.org/library/papers/20454933 | PubMed |
| 4 | 23385644 | Lack of kinin B₁ receptor potentiates leptin action in the liver. | J Mol Med (Berl) | 2013 | https://conductscience.org/library/papers/23385644 | PubMed |
| 5 | 34698778 | Strengthening the Reporting of Observational Studies in Epidemiology Using Mendelian Randomization: The STROBE-MR Statement. | JAMA | 2021 | https://conductscience.org/library/papers/34698778 | PubMed |
| 6 | 34447378 | Crosstalk Between Plasma Cytokines, Inflammation, and Liver Damage as a New Strategy to Monitoring NAFLD Progression. | Front Immunol | 2021 | https://conductscience.org/library/papers/34447378 | PubMed |
| 7 | 26783377 | Serum Cytokine of IL-10 and IL-12 in Chronic Liver Disease: The Immune and Inflammatory Response. | Dis Markers | 2015 | https://conductscience.org/library/papers/26783377 | PubMed |
| 8 | 29164242 | Mendelian Randomization. | JAMA | 2017 | https://conductscience.org/library/papers/29164242 | PubMed |
| 9 | 35447114 | Leukemia inhibitory factor protects against liver steatosis in nonalcoholic fatty liver disease patients and obese mice. | J Biol Chem | 2022 | https://conductscience.org/library/papers/35447114 | PubMed |
| 10 | 27992443 | Pro-Inflammatory Cytokines but Not Endotoxin-Related Parameters Associate with Disease Severity in Patients with NAFLD. | PLoS One | 2016 | https://conductscience.org/library/papers/27992443 | PubMed |
| 11 | 29785076 | Role of osteoprotegerin/receptor activator of nuclear factor kappa B/receptor activator of nuclear factor kappa B ligand axis in nonalcoholic fatty liver disease. | World J Gastroenterol | 2018 | https://conductscience.org/library/papers/29785076 | PubMed |
| 12 | 35247611 | Serum amyloid A1 exacerbates hepatic steatosis via TLR4-mediated NF-κB signaling pathway. | Mol Metab | 2022 | https://conductscience.org/library/papers/35247611 | PubMed |
| 13 | 29967350 | Mechanisms of NAFLD development and therapeutic strategies. | Nat Med | 2018 | https://conductscience.org/library/papers/29967350 | PubMed |
| 14 | 32413340 | Global prevalence, incidence, and outcomes of non-obese or lean non-alcoholic fatty liver disease: a systematic review and meta-analysis. | Lancet Gastroenterol Hepatol | 2020 | https://conductscience.org/library/papers/32413340 | PubMed |
| 15 | 24055326 | Observational research--opportunities and limitations. | J Diabetes Complications | 2013 | https://conductscience.org/library/papers/24055326 | PubMed |
| 16 | 31292134 | Osteoprotegerin Promotes Liver Steatosis by Targeting the ERK-PPAR-γ-CD36 Pathway. | Diabetes | 2019 | https://conductscience.org/library/papers/31292134 | PubMed |
| 17 | 26050253 | Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression. | Int J Epidemiol | 2015 | https://conductscience.org/library/papers/26050253 | PubMed |
| 18 | 20858684 | Adipose tissue dysfunction signals progression of hepatic steatosis towards nonalcoholic steatohepatitis in C57BL/6 mice. | Diabetes | 2010 | https://conductscience.org/library/papers/20858684 | PubMed |
| 19 | 38015590 | Altered profiles of circulating cytokines in chronic liver diseases (NAFLD/HCC): Impact of the PNPLA3I148M risk allele. | Hepatol Commun | 2023 | https://conductscience.org/library/papers/38015590 | PubMed |
| 20 | 33200014 | Tumor necrosis family receptor superfamily member 9/tumor necrosis factor receptor-associated factor 1 pathway on hepatitis C viral persistence and natural history. | World J Hepatol | 2020 | https://conductscience.org/library/papers/33200014 | PubMed |
Cited by3
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 4 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41795980 | [Liver-bone axis: novel mechanisms and strategies for MAFLD regulation]. | Zhonghua Gan Zang Bing Za Zhi | 2026 | https://conductscience.org/library/papers/41795980 | PubMed |
| 41617025 | HIF-2α induction in de novo lipogenesis in metabolic dysfunction-associated steatohepatitis is dependent on IL-21 signaling. | J Biol Chem | 2026 | https://conductscience.org/library/papers/41617025 | PubMed |
| 41036025 | Perturbation of Circulating Inflammatory Proteins Mediates the Relationship Between Cholecystectomy and Nonalcoholic Fatty Liver Disease: A Multivariate and Mediation Mendelian Randomization Study. | Health Sci Rep | 2025 | https://conductscience.org/library/papers/41036025 | PubMed |
Genes4
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CCL11 | 6356 | PubTator's text mining | https://conductscience.org/library/genes/6356 | NCBI Gene |
| LIF | 3976 | PubTator's text mining | https://conductscience.org/library/genes/3976 | NCBI Gene |
| TNFRSF11B | 4982 | PubTator's text mining | https://conductscience.org/library/genes/4982 | NCBI Gene |
| TNFRSF9 | 3604 | PubTator's text mining | https://conductscience.org/library/genes/3604 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39720899
GET https://conductscience.org/api/papers/v1/39720899/references?page=2